Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1LCL

CHARCOT-LEYDEN CRYSTAL PROTEIN

Summary for 1LCL
Entry DOI10.2210/pdb1lcl/pdb
DescriptorLYSOPHOSPHOLIPASE (2 entities in total)
Functional Keywordscharcot-leyden crystal protein, serine esterase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasmic granule: Q05315
Total number of polymer chains1
Total formula weight16499.89
Authors
Acharya, K.R.,Leonidas, D.D. (deposition date: 1996-01-18, release date: 1997-01-11, Last modification date: 2024-02-14)
Primary citationLeonidas, D.D.,Elbert, B.L.,Zhou, Z.,Leffler, H.,Ackerman, S.J.,Acharya, K.R.
Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
Structure, 3:1379-1393, 1995
Cited by
PubMed Abstract: The Charcot-Leyden crystal (CLC) protein is a major autocrystallizing constituent of human eosinophils and basophils, comprising approximately 10% of the total cellular protein in these granulocytes. Identification of the distinctive hexagonal bipyramidal crystals of CLC protein in body fluids and secretions has long been considered a hallmark of eosinophil-associated allergic inflammation. Although CLC protein possesses lysophospholipase activity, its role(s) in eosinophil or basophil function or associated inflammatory responses has remained speculative.
PubMed: 8747464
DOI: 10.1016/S0969-2126(01)00275-1
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon